Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Should the pT2 tumor classification for renal cell carcinoma be subdivided according to tumor size?

Nature Clinical Practice Urology volume 4, pages 648–649 (2007)Cite this article

boxed-textKlatte T et al. (2007) Prognostic impact of tumor size on pT2 renal cell carcinoma: an international multicenter experience. J Urol 178: 35–40

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Van Poppel H et al. (1997) Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol 158: 45–49

    Article  CAS  Google Scholar 

  2. Madbouly K et al. (2007) Microvascular tumor invasion: prognostic significance in low-stage renal cell carcinoma. Urology 69: 670–674

    Article  Google Scholar 

  3. Dall'Oglio MF et al. (2007) Microvascular tumor invasion, tumor size and Fuhrman grade: a pathological triad for prognostic evaluation of renal cell carcinoma. J Urol 178: 425–428

    Article  Google Scholar 

  4. Lang H et al. (2004) Prognostic value of microscopic venous invasion in renal cell carcinoma: long-term follow-up. Eur Urol 46: 331–335

    Article  Google Scholar 

  5. Atzpodien J et al. (2005) Adjuvant treatment with interleukin 2 and interferon-α2a-based chemoimmunotherapy in renal cell carcinoma post tumour nephrectomy: results of a prospectively randomised trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN). Br J Cancer 92: 843–846

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Rachel Murphy, Associate Editor, Nature Clinical Practice.

Author information

Author notes

  1. Department of Urology, University Hospital K. U. Leuven, B-3000 Leuven, Belgium hendrik.vanpoppel@uz.kuleuven.ac.be

Authors and Affiliations

  1. H Van Poppel is Chairman of the Department of Urology, University Hospital Gasthuisberg, Katholieke Universiteit Leuven, Leuven, Belgium.,

    Hein Van Poppel

Authors
  1. Hein Van Poppel
    View author publications

    You can also search for this author in PubMed Google Scholar

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Van Poppel, H. Should the pT2 tumor classification for renal cell carcinoma be subdivided according to tumor size?. Nat Rev Urol 4, 648–649 (2007). https://doi.org/10.1038/ncpuro0939

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0939

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing